TWO SIGMA ADVISERS, LP - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 40 filers reported holding SOLENO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$43,000
-21.8%
232,000
-5.8%
0.00%
Q1 2022$55,000
-66.3%
246,400
-38.1%
0.00%
Q4 2021$163,000
-76.3%
398,000
-46.5%
0.00%
-100.0%
Q3 2021$688,000
+49.2%
744,000
+84.1%
0.00%
+100.0%
Q2 2021$461,000
-16.8%
404,100
-8.1%
0.00%
-50.0%
Q1 2021$554,000
-40.2%
439,700
-8.3%
0.00%0.0%
Q4 2020$926,000
-47.3%
479,600
-31.5%
0.00%
-60.0%
Q3 2020$1,758,000
+5760.0%
700,400
+5012.4%
0.01%
Q2 2020$30,00013,7000.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders